Dallas Matthew D 4
4 · AVEO PHARMACEUTICALS INC · Filed Feb 2, 2018
Insider Transaction Report
Form 4
Dallas Matthew D
VP, Finance
Transactions
- Award
Stock Option (right to buy)
2018-02-01+250,000→ 250,000 totalExercise: $3.08Exp: 2028-02-01→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in equal monthly installments from February 1, 2018, through February 1, 2022, subject to the Reporting Person's continued service to the Company.